Cleveland State University

EngagedScholarship@CSU
Chemistry Faculty Publications

Chemistry Department

8-2-1994

Dissection of An Antibody-Catalyzed Reaction
Jon D. Stewart
Pennsylvania State University

Joseph F. Krebs
Scripps Research Institute

Gary Siuzdak
Scripps Research Institute

Anthony J. Berdis
Cleveland State University, A.BERDIS@csuohio.edu

David B. Smithrud
Pennsylvania State University

See next page for additional authors
Follow this and additional works at: https://engagedscholarship.csuohio.edu/scichem_facpub
Part of the Biochemistry Commons, and the Chemistry Commons

How does access to this work benefit you? Let us know!

Publisher's Statement
© 1994 by The National Academy of Sciences
Recommended Citation
Stewart, Jon D.; Krebs, Joseph F.; Siuzdak, Gary; Berdis, Anthony J.; Smithrud, David B.; and Benkovic,
Stephen J., "Dissection of An Antibody-Catalyzed Reaction" (1994). Chemistry Faculty Publications. 184.
https://engagedscholarship.csuohio.edu/scichem_facpub/184

This Article is brought to you for free and open access by the Chemistry Department at EngagedScholarship@CSU.
It has been accepted for inclusion in Chemistry Faculty Publications by an authorized administrator of
EngagedScholarship@CSU. For more information, please contact library.es@csuohio.edu.

Authors
Jon D. Stewart, Joseph F. Krebs, Gary Siuzdak, Anthony J. Berdis, David B. Smithrud, and Stephen J.
Benkovic

This article is available at EngagedScholarship@CSU: https://engagedscholarship.csuohio.edu/scichem_facpub/184

7404

Dissection of an antibody-catalyzed reaction
Jon D. Stewart , Joseph F. Krebs , Gary Siuzdak , Anthony J. Berdis , David B. Smithrud ,
and Stephen J. Benkovic

ABSTRACT
Antibody 43C9 accelerates the hydrolysis of a p-ni1ro8Dilide by a
factor of 2.5 x 105 over the background
rate In addition to catalyzlna the hydrolysis or a series or aromatic esten. Since this
represents one of the largest rate acceleratioas achieved with an antibody, we have
undertaken a series of studies aimed at
uncovering the catalytic mechanism of
43C9. The immunogen, a pbosphonamldate, was designed to mimic the geometric
and electronk cbaracteristics of the tetrahedral Intermediate that forms upon nudeophlllc attack by hydroude on the amIde substrate. Further studies, however,
revealed that the catalytic mechanism Is
more complex and Involves the fortuitous
formation of a covalent acyl-antibody Intermediate as a comequeace of complementary side chain residues at the antibody-bindlng site. Several lines of evlden ce indicate that the catalytic
mechanism Involves two key residues: lllsL91, wblcb acts as a nudeophile to form
the acyl-antlbody Intermediate, and ArgL96, which stabllbes the anionic tetrahedral moieties. Support for tllJs mechanism
derives from the results of site-directed
mutagenesis experiments and solvent deuterium Isotope effects as wen as direct
detedloa of the acyl-antibody by electrospray mass spectrometry. Despite its par•
Ual recapitulation of the coune of action of
emymic counterparts, the reactivity or
43C9, like other antibodies, Is apparently
limited by Its afflnlty for the Inducing
lmmunogen. To go beyond tllJs level, one
must Introduce additional catalytic func.
tlonality. particularly general add-base
catalysis, through either Improvements In
transition-state analog design or sltespedftc mutagenesis.
Antibodies are capable of catalyzing a variety of chemical transformations (1-5).
Antigens have been fabricated that structurally resemble high-energy intermediate
species anticipated in a chemical reaction,
which can then be used to induce antibodies whose binding energy should stabilize
such intermediates or their related transition states along the reaction pathway. For
an antibody with a typical 0.1 nM affinity
for its antigen and 1 mM affinity for its
substrate (defined as the constant for
antibody·antigen/substrate dissociation),

the difference in the free energy of binding
is :o::9.6 kcal·mo1-1 (1 cal = 4.184 J), which
translates to an increase in kinetic turnover
of ==107 if all of the difference in binding
energy is realized in catalysis. In practice,
however, most catalytic antibodies do not
efficiently convert this binding energy to
catalysis. Consequently, those such as
43C9, the subject of this review, which
exhibitlargerateenhancementsoflOS-106,
are of particular interest. The investigation
of their mechanism of action is instructive
from at least two related points of view: (i)
what fundamental principles of catalysis
are responsible for the rate acceleration,
and (ii) what features of the transition-state
mimic and its complementary antibody site
are the primary contributors to catalysis.
This information can serve as the basis for
obtaining catalytic antibodies possessing
high catalytic turnover numbers either
through improvements in the design of the
eliciting antigen/hapten or through subsequent modifications of the binding site
through chemical or genetic methods.
Evidence for NudeopbUlc Catalysis by a
Catalytic Andbody

Catalytic antibody 43C9 was selected from
a panel of 44 antibodies that bound the
phosphonamidate transition-state mimic 4
(Scheme I) (6). The intent was to find
catalytic antibodies capable of accelerating
the hydrolysis of aromatic amide 1. Amide
hydrolysis at slightly alkaline pH involves
a putative zwitterionic tetrahedral species-one of several tetrahedral species
interconverting through proton transfers
and flanked by tetrahedral transition states
for their formation and decomposition (7).
Phosphonate derivatives have acted as
transition-state inhibitors for various esterase enzymes and thus closely mimic the
stereoelectronic features of the transition
states for hydrolysis of carboxylic esters
and amides (8). The antibody 43C9 accelerated hydrolysis of 1 by a factor of 2.5 x
105 over the hydrolysis rate measured in
the absence of antibody at pH 9.0. By
applying transition-state theory, the value
of AAGt is calculated to be - 7 .5
kcal·mo1- 1 (9). The difference between
binding of 1 and 4 to the antibody is an
index of the available transition-state binding energy. The binding constant ofhapten

at pH 9.0 was obtained by titrating the
antibody with 4 (monitoring the quenching
of intrinsic antibody fluorescence); the K d
value equals 0.8 ± 0.2 nM. The binding
constant of 1 at pH 9.0 was obtained from
K m and equals 180 ± 20 µ.M. The ratio of
K d /K m provides a A.AGt equal to - 7.2
kcal-mo1- 1. The agreement between the
two measures of transition-state stabiliz.ation achieved by the catalytic anb"body is
more than satisfactory. One might conclude from this superficial analysis that the
hydrolysis catalyzed by 43C9 proceeds by
a simple, one-step mechanism. The experimental facts, however, reveal another
story.
The anb"body-catalyzed hydrolysis of
p-nitrophenyl ester 2a and p-nitroanilide I
has been examined by both pre- and
steady-state kinetic techniques (10). The
steady-state Micbaelis-Menten parameters, kc.tiKm and kcat, as a function of pH
are shown in Fig. 1. The data can be fit
either to a reaction mechanism involving
the titration of a group at the antigenbinding site whose dissociation promotes
substrate hydrolysis or to one that features a change in the rate-limiting step
around a central antibody-bound intermediate species due to changes in pH. For
the p-nitrophenyl ester, the rate constant
for p-nitrophenol release (measured independently) approximates kcat in the pHindependent region (pH > 9). Thus, the
apparent pl(. of 9 found for both substrates in the pH rate profiles cannot be
due to dissociation of a common acidbase group involved in binding or catalysis. Further support for this conclusion
obtains from the absence of pH-dependent binding of I, a competitive inhibitor
of ester hydrolysis that should be sensitive
to the ionization state of an active-site
acid-base group. The 10' difference in kcat
at pH > 9.0 between the two substrates
also rules out any mechanism involving a
shared conformational change step such
as activation of an antibody·substrate
complex that is rate-limiting in that region.
The pH independence of K m values for
both 1 and 2a required by the similar pH
behavior of kca, and kat!Km , however,
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Scheme I

suggests that there is no significant accumulation of the putative intermediate.
Attempts to detect a steady-state intermediate such as an acyl-antibody at low
pH (pH 7.0) where its accumulation is
more favorable by stopped-flow or rapidquench methods were unsuccessful (10).
Single 180 incorporation into the acid
product 3 observed in the presence of
H i 180 is consistent with an acyl species
and definitively rules out a symmetrical
tetrahedral intermediate (11). However,
using electrospray mass spectrometry, a
covalently bound species of mass weight
equivalent to an acylated antibody was
recently observed at pH 5.9, which represented -10% of the total antibody species, thus reinforcing our choice of interpretation. This species was not detected
in a similar experiment in the presence of
hapten 4. The data were therefore analyzed by using the kinetic sequence described in Scheme II.
The substrate specificity of 43C'9 was
further extended to include a series of
p-substituted phenyl esters 2b-e (12). Interestingly, little or no reactivity was observed with the C01TCsponding m-nitrophenyl ester or anilide or the p-chlorosubstituted anilide, despite the fact that
the m-nitro compounds are bound as well
as their respective p-nitro derivatives.
This suggests that a precise, stercochemical orientation of the substrate is necessary within the active site. Since the pHdependent hydrolysis of esters 2b-e by
43C'9 exhibits kcat and lea,./ K m pH rate
profiles similar to the p-nitro derivatives,

the data were analyzed identically. Values
for the estimated rate constants are listed
in Table 1.
The pH rate profiles for kcat are thus
indicative of a change in rate-limiting step
from hydroxide ion-mediated hydrolysis
of a steady-state acyl intermediate at low
pH to either product release (p-nitrophenyl ester) or acylation in the case of esters
lb-e and the anilide at high pH values.
The pH rate profiles for kcat/Km arise
from a similar pH-dependent change
from steps involving deacylation to those
reflecting acylation. The apparent pK.
observed in the kcat/ K m versus pH rate
profiles for the esters shifts from 8.9
(p-Cl) to 9.5 (p-CH 3) and reflects the
small change in L 2 consistent with a late
transition state in the acylation reaction
and, conversely, attenuation of the substituent effect in the reverse deacylation.
Note that the limitation of rate-limiting
product release imposed by p-nitrophenol is relieved by changing the p substituent, although the advantage is offset by
a slower acylation rate.
The rates of the antibody-catalyzed acy·
lation (ki) for this series of substrates correlate with u, affording a p value of +2.3.
In contrast, a similar correlation for the
hydrolysis rates for the same esters in the
absence of antibody provides a p value of
+0.8 (12). For comparison, hydrolysis of
phenyl esters via a general base mechanism or by nucleopbilic attack by hydroxide ion is characterized by p values as low
as 0.5-0.7 (13, 14) to 1.0-1.2 (13, 15, 16),
respectively. The large p value observed
1
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Flo. 1. pH rate profiles for 43C9-catalyzed hydrolysis of p-nitropbenyl ester 2a (Left) and
p-nitroanilide I (Right).

for the antibody-catalyzed reaction is more
characteristic of nucleophilic attack and
expulsion of a charged leaving group by a
nitrogen nucleophile, such as imidazole
(13-15). Thus, the substituent effect provides further support for an acyl intermediate and against a one-step general base or
nucleophilic attack mechanism for hydrolysis. The inability of 43C'9 to protonate its
leaving group is underscored by the dramatic 80-fold decrease in kcatestimated for
the p-chloroanilide species.
Collectively from the kinetic and thermodynamic binding measurements, a free
energy reaction coordinate diagram was
constructed for hydrolysis of the p-nitrosubstituted ester and anilide (Fig. 2) (10).
There are several striking features of the
two reaction profiles. One is the high
stability of the antibody Ab·P1·P2 complex, which has a /Ji.G equal to 7-12
kcal·mol- 1 lower than the respective uncomplexed substrates. This tight product
complex ultimately limits the rate of ester
hydrolysis at high pH. The second noteworthy feature is the increased kinetic
barrier for the formation of Ab-I from the
amide relative to the ester substrate so
that this step ultimately limits amide turnover by the antibody at high pH. This free
energy profile may provide a glimpse of
bow nonoptimized enzymes may have
functioned with their efficiency of turnover hampered by the unevenness in the
/Ji.G barriers for the various ground states
and their respective transition states. We
will return to a more direct comparison of
43C'9 to an esterase enzyme later, but the
remarlcable finding to emphasize now is
bow far the mechanism of action of 43C'9
has departed from the simple hydrolysis
implicit in the original hapten design. One
simple rationale is that covalent active site
chemistry becomes more probable the
higher the affinity of the antibody for the
transition-state mimic, provided that nucleophilic side chains are made available
through a requirement for charge neutralization or hydrogen bonding in hapten
binding.
Construction of the 43C9
Mode1Structure
Recent mechanistic studies of 43C'9 have
made use of site-directed mutagenesis to
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Scheme II

probe the roles of individual residues involved in binding and catalysis. These
experiments were guided by the previously discussed kinetic studies as well as
a computer model of the 43C9 Fv fragment with bound ligands (17). Computer
modeling of antibody variable (V) regions
takes advantage of both the modular nature of antibody structures as well as the
high degree of conservation of tertiary
structure between antibodies with widely
divergent binding specificities. The 43C9
model was constructed in several steps
using the previously published Antibody
Structural data base (18, 19). Briefly, sequence comparisons were used to select
the framework regions, then the complementarity-determining loops were constructed, and finally the V L (L, light chain)
and VH (H, heavy chain) regions were
paired. The first step was to compare the
primary sequence of the L and H chains of
43C9 with those of antibodies whose
three-dimensional structures are known.
For 43C9, the L chain most resembled
that of the anti-phosphorylcholine antibody McPC603, while the H chain of 43C9
was most similar to that of the antilysozyme antibody Dl.3. These data base
sequences were then modified to match
those of 43C9. The H3 loop is the most
difficult to model as a result of its high
diversity in sequence and length, and the
likely conformation of the 43C9 H3 loop
was determined by a series of steps after
examining both the VLIVH interface and
the binding of antigen (see below).
Once constructed, the antibody model
revealed a T-shaped cleft for the antigenbinding region. The side chain of Arg-L96
is located at the vertex of the T, where it
is situated to form a salt bridge with the
negatively charged phosphonamidate
group of the hapten. Such interactions
have previously been observed in antibodies and other proteins that bind phosphorus oxyanions (for example, see refs.
20 and 21). Once docked in this position,
the hapten fits snugly into the antigenbinding pocket. Furthermore, this binding mode clarifies the position of the H3
loop, since only a few conformations are
available that do not involve extensive
steric clashes with the protein or antigen.

The amide substrate was docked analogously (Fig. 3) (22). The p-nitrophenyl
portion of the substrate lies within a cleft
whose walls are formed by Tyr-L32 and
the -H3 loop with the side chain of ArgHlOOA positioned to form a polar hydrogen bond with the nitro group of the
hapten. The acyl portion lies on top of the
side chain of Trp-H52 and has extensive
contacts with the Hl and H2 loops.
The computer model has provided a
number of insights into the catalytic
mechanism of 43C9. The proximity of the
substrate carbonyl to residues His-L91,
Arg-L96, and Tyr-H95 suggested that
these residues play roles in catalysis.
Specifically, the N 8 of His-L91 is located
... 4_5 A from the carbonyl carbon of the
substrate. On the other hand, the side
chain of the other active site histidine
(His-H35) is >7 A from the substrate
carbonyl, too far for this imidazole to act
as a nucleophile. The side chain of HisH35, moreover, is involved in an extensive hydrogen bonding network at the
bottom of the antigen-binding pocket,
suggesting that this residue plays a structural role in maintaining the conformation of the binding pocket. The hydroxyl
of Tyr-H95 appears to hydrogen bond
with one of the oxygens of the hapten;
this proximity suggested its involvement
along with Arg-L96 in stabilizing the tetrahedral intermediates or transition
states. The accuracy of the model will
ultimately be tested by x-ray crystallography, but to date its predictions have
proven remarkably accurate (see below).
Appllcatioo of the Proton Inventory
Technique to Antibody Catalysis

As probes of enzyme mechanisms, the
solvent isotope effect and proton inventory have found their greatest use with
the serine proteases (23). This technique
was used to further evaluate the proposed catalytic mechanism of 43C9,
fleshed out in view of the modeled antibody-substrate complex (Fig. 3). Proton
inventories of kcat and kcai/ Km at pL 8 are
bowed downward for the 43C9-catalyzed
hydrolysis of p-chlorophenyl ester 2b. At
this pL value, breakdown of the acyl-

Table 1. Kinetic parameters for p-substituted ester hydrolysis by antibody 43C9 at pH 9.3
R
kca.. s - 1
Km, µ.M
k1, µ.M·s- 1 k-1, s - 1 k2, s - 1 k-2, s - 1 ks, s - 1
N02
=25
53
1.3
25 :!: 4
2:180
c::3600
40 :!: 5
CH3CO
=0.87
... 3000
..::1400
>700
No value • 1 . 7
CHO
1.0 :!: 0.1
250 :!: 80
CJ
1.7 :!: 0.2
720 :!: 220
0.15
89 :!: 6
=2.2
c::1200
... 900
CH3
0.15 :!: 0.03
... 3000
•0.25
..::1900
>600
k3 (60 µ.M·s- 1) and Jc,, (330 :!: 40 s - 1) arc assumed to be constant for all substrates since the
acyl portion is identical in all substrates. Data are from Gibbs et al. (12).

antibody intermediate represents the
rate-limiting step. A bowed downward
proton inventory can most easily be interpreted in terms of a mechanism involving the transfer of two or more protons in
a single rate-limiting transition state
(24)-in this case, breakdown of the tetrahedral intermediate by hydroxide ion
attack on the putative acyl-imidazole.
Since the pl(. for the tetrahedral intermediate species is close to that of ArgL96 [the pK a for an analogous tetrahedral
intermediate is ""'12.9 (25)), Arg-L96 either transfers a proton to the negatively
charged oxygen of the tetrahedral intermediate or is involved in strong hydrogen
bonding interactions with the oxygen.
The second proton observed from the
proton inventory likely arises from a proton transfer to the imidazole of the His
nucleophile. At pL 9.5, a solvent isotope
effect of ""'1.2 on kcat! K m is obtained for
the 43C9-catalyzed hydrolysis of p-chlorophenyl ester 2b. For all intents and
purposes, this is most likely not a solvent
isotope effect on the acylation step of the
reaction but instead reflects a viscosity
effect on substrate binding. All of these
solvent isotope effects are consistent
with the change in rate-limiting steps
required by the kinetic sequence of
Scheme m.
Probing the Active Site of 43C9
by Mutagenesi.1

Using the single-chain Fv version of 43C9,
which retains the kinetic parameters of
the parent monoclonal antibody (26), a
series of site-directed mutagenesis studies
were undertaken. The His-L91 to Gin
(H-L91-Q) mutant, which retains a degree
of hydrogen bonding but no nucleophilic
capability, possessed no detectable catalytic activity when assayed against the
p-chlorophenyl ester substrate 2b (22).
This finding reflects at least a 50-fold
decrease in catalytic activity. On the other
hand, the affinity of this mutant for ligands
is essentially unchanged from that of the
wild type (Table 2). The results of the
binding assays demonstrated that the lack
of observed catalysis was not due to large
changes in antibody structure or to a lack
of substrate binding. Hapten binding was
used as a surrogate for substrate binding
because of the rapid spontaneous hydrc>lysis of the ester substrates and the weak
binding of anilide 1. Measurement of the
binding affinity for the hydrolysis products, acid 3 and p-nitrophenol, which correspond to each arm of the L-shaped
hapten, takes advantage of the strong
binding of these products to localize
changes in hapten binding to one region of
the combining site. Collectively, these observations support a role for His-L91 as
the nucleophile in catalysis. Moreover, no
covalent intermediate was detected by
electrospray mass spectrometry when the
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H-L9I-Q mutant was incubated withp-nitrophenyl ester la. Substitution of Ser or
Glu for His-L91 gave mutants with no
appreciable activity, despite their ability
to bind ligands. Substitution of a Cys
residue at position L91 apparently interferes with the formation of the VL intrachain disulfide bond involving the naturally occurring Cys residues at L23 and
L88 since no folded protein was recovered
(J.D.S., V. A. Roberts, E. D. Getzoff,
and S.J.B., unpublished data).
Substitution of Arg-L96 with Gin removes the positive charge while retaining
some hydrogen bonding ability. The
R-L96-Q mutant is catalytically inactive,
supporting a role for this residue in catalysis. In addition, the affinity of this mutant
for the hapten was reduced some 20-fold,
while the affinity for the other ligands was
relatively unaffected (17). These results

Tyr-H95 in transition-state binding, this
residue was changed to Phe. The Y-H95-F
mutant possessed ==50% of the wild-type
activity, in accord with the pH rate profiles obtained for the wild-type 43C9,
which did not exlubit involvement of a
dissociable Tyr residue (22).

support the notion that the side chain of
Arg-L96 interacts specifically with the
phosphonamidate, since it is this group
that distinguishes the hapten from either
of the products. Substitution of His for
Arg-L96 gave a mutant (R-L96-H) that
lacked catalytic activity. Moreover, its
affinity for all ligands decreased substantially, suggesting some reorganization of
the antigen-binding pocket to accommodate the larger side chain, which is consistent with the tight packing of side
chains of the amino acids that form the
floor of the antigen-binding site (M. W.
Crowder, J.D.S., V. A. Roberts, E. D.
Getzoff, and S.J.B., unpublished data).
Substitution of His-H35 with Asn or Phe
also appears to disrupt the active site
structure, as evidenced by their decreased
affinities for the various ligands (22). Finally, to probe the role of the hydroxyl of

F10. 3. Model of 43C9 Fv frapient with bound amide substrate. Selected residues that line
the antigen-binding site are highlighted. The VL segment is on the left and the V H segment is
on the right. His-L91, the putative nucleophile, lies near the scissile carbonyl of the substrate
and Arg-L96 is poised to act as an oxyanion hole. The hydroxyl of Tyr-H95 lies near the
carbonyl oxygen, while the side chain ofTyr-L32 forms one wall of the antigen binding pocket.

We have explored the possibility of introducing residues to accomplish the protonation of either the leaving group or the
tetrahedral species in order to lower the
free energy requirements during passage
along the reaction coordinate. The proximity of Tyr-L32 to the leaving group
suggested that substituting this residue
with one capable of proton transfer might
accomplish our goal. Replacement ofTyrL32 with His or Glu provided no observable increase in hydrolysis of the p-chlorophenyl ester substrate at pH 7-8.5,
where the acylation step is mainly ratelimiting (ref. 22; J.D.S., D.B.S., V. A.
Roberts, E. D. Getzoff, and S.J.B., unpublished data). This indicates that the
side chain is improperly positioned for
proton donation or, in the case of the His
residue, its p.Ka is below pH 7. The latter
is a strong possibility because of the electropositive environment of the antigenbinding site, resulting from Arg residues at
positions L96 and HIOOA. Similarly, the
side chain of Tyr-H95 is located near the
scissile carbonyl and also provides an
opportunity for proton donation to the
tetrahedral species. Unfortunately, the
Y-H95-H mutation decreased substrate
binding to the extent that only the p-nitrophenyl ester was useful as a substrate
due to solubility limitations. For this substrate at pH 7.45, where deacylation is
rate-limiting, the keat value of the mutant
was reduced 4-fold relative to that of the
wild type (22).
A carboxylate side chain was placed
adjacent to the N• of His-L91 by substituting Glu for Gln-1.89. We anticipated
that the resulting hydrogen bond would
help orient the N3 ofHis-L91 for nucleophilic attack and might also facilitate proton transfer. Unfortunately, the Q-L89-E
mutant displayed only =50% of the wildtype activity (J.D.S., V. A. Roberts,
E. D. Getzoff, and S.J.B., unpublished
data). Collectively, these results underscore the exacting constraints that must
be satisfied to improve turnover.
Our final approach to rationally improve catalysis by 43C9 was to increase
product release since this step is ratelimiting for p-nitropbenyl ester hydrolysis at high pH values. As noted above, the
side chain of Arg-HIOOA is positioned to
form a charged hydrogen bond with the
nitro group of the hapten. Presuming that
this hydrogen bond might be at least
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late a number of characteristics of an
enzyme whose evolution has been directed by increased catalytic efficiency.
Covalent catalysis allows a difficult
chemical transformation to be broken
Ab+S
into more manageable units and represents a common theme in enzymecatalyzed amide hydrolysis. The use of a
His residue as the nucleophile, however,
appears to be unprecedented. On the
other hand, this participation is reasonable since His and Tyr (27) are the only
residues acting in the absence of general
acid-base catalysis that might be expected to reversibly form acyl-antibody
H
intermediates. Nature has circumvented
) I<,
this problem in enzymes by constructing
multiresidue networks involving general
base catalysis; for example, the Cys-His
ion pair in the case of subtilisin or the
catalytic triad of the serine proteases.
The use of an oxyanion hole to stabilize
the tetrahedral transition states and inScheme Ill
termediates has also been reproduced by
partially responsible for slow product re- Compartaon or the Mechanism or 43C9
43C9. In the case of carboxypeptidase A,
lease, Arg-HlOOA was replaced with Gin. witll Tbo8e ol AnaJoeous F.nzymes
which also employs an Arg residue in this
Thermodynamic binding measurements
role, this interaction contributes 6-8
indicated that the affinity o f the From the outset, our goal has been to kcal·mo1-1 to transition-state stabilizaR-HlOOA-Q mutant for p-nitrophenol had produce antibody catalysts whose effi- tion (28). Unfortunately, we were unable
been reduced 4.3-fold relative to that of ciencies match those of highly evolved to measure the contribution in free enthe wild type. Furthermore, direct mea- enzymes. This invites two questions: (i) ergy of Arg-L96 to transition-state stabisurements o f the on and off rates for to what extent have we succeeded in lization in the case of 43C9 since the
p-nitrophenol binding to this mutant (22 producing effective catalysts, and (ii) to catalytic activity of the R-L96-Q mutant
µ.M-s-1 and 103 s-1, respectively) indi- what extent do catalytic antibodies re- was below our detection limits.
cated that the off rate was increased semble their enzymic counterparts? AnCondading Remarks
2.5-fold relative to the wild type. This tibody 43C9 is a potent catalyst for anilincreased off rate was manifested by a ide and ester hydrolysis at p H > 9.0, with How can the lessons learned from studies
kcat value of 100 s-1 for the p-nitrophenyl kca 1 values within a factor of 25 and 2, of 43C9 be applied to creating more efester substrate at pH 10, 2.5-fold higher respectively, of chymotrypsin at pH 7.0 fective antibody catalysts? First, our rethan that for the wild-type antibody in the (10). By this criterion, then, we have sults have underlined the importance of
pH-independent region (D.B.S., V. A. succeeded in producing a catalyst with high affinity for the transition-state analog, provided that the antigen accurately
Roberts, E. D. Getzoff, and S.J.B., un- remarkable activity.
published data). This provides an examMechanistic studies of 43C9 have represents the transition state for a given
ple of a means for relieving product in- shown that an antibody whose evolution reaction. It is worth noting that no 43C9
hibition without deleterious effects on has been directed toward tighter binding mutant whose Kd for the transition-state
of a transition-state analog can recapitu- analog was > 1 nM displayed catalytic
the overall turnover o f the antibody.
Table 2. Thermodynamic dissociation constants for ligand binding and steady-state kinetic parameters for
p-chloropbenyl ester hydrolysis at pH 8.S and 2S"C by wild-type and mutant 43C9 single-chain antibodies
Kinetic parameters

Kd
Protein

Hapten, nM

Wild type
Y-L32-H*
Y-L32-E*
Q-L89-E*
H-L91-Q*
H-L91-S*
H-L91-E*
H-H3S-N*
H-H3S-F*
R-L96,Qf
Y-H9S-F*
Y-H9S-H*
R-HlOOA-Qt

Sl
0.67 ± 0.3S
s2
:s2

Acid, µM
IS± 1
12 ± 3
1S ± 3
16 ± 3
17 ± 3
24 ± 4
>200
100 ± 10
1S ± 2
31 ± 8
2S ± 8
21 ± 6
1S ± 3

Phenol, µM
0.6
0.38
4.3
0.64
O.S3
2.0
12

± 0.1
± 0.09
± 0.4
± 0.21
:S}
± 0.16
:st
± 0.3
3{i() ± 10
± 1
16 ± 2
s.s ± l.S
13 ± 6
1.4 ± 0.1
16 ± 2
0.96 ± 0.16
s2
0.65 ± 0.22
s2
0.70 ± 0.18
Sl
2.6 ± o.s
N A , no detectable catalytic activity; SA, slight activity; N D , not determined.
*Data are from Stewart et al. (22).
*J.D.S., V . A . Roberts, E . D. Getzoff, and S.J.B., unpublished data.
fData are from Roberts et al. (17).
to.B.S., V. A. Roberts, E. D. Getzoff, and S.J.B., unpublished data.

k.:.t, s-1

0.46 ± o.os
0.17 ± 0.01
NA
0.22 ± 0.02
NA
SA
NA
NA
NA
NA
0.18 ± 0.01
NA
ND

K-.,µM
470 ± l(iO
1300 ± 100
NA
1700 ± 200
NA
SA
NA
NA
NA
NA
990 ± 90
NA
ND
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